Form 8-K - Current report:
SEC Accession No. 0001641172-25-003216
Filing Date
2025-04-08
Accepted
2025-04-08 16:05:29
Documents
14
Period of Report
2025-04-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44755
2 ex16-1.htm EX-16.1 4603
  Complete submission text file 0001641172-25-003216.txt   226850

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pulm-20250404.xsd EX-101.SCH 3018
4 XBRL LABEL FILE pulm-20250404_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pulm-20250404_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 25821950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)